BRIEF published on 04/07/2025 at 07:08, 1 year 5 months ago Swiss Re Named Co-Investment Manager for GAM Catastrophe Bond Funds Investment Management Partnership Swiss Re Catastrophe Bonds Insurance-Linked Securities
BRIEF published on 04/07/2025 at 07:08, 1 year 5 months ago Swiss Re nommé co-gestionnaire d'investissement pour les fonds GAM Catastrophe Bond Partenariat Swiss Re Gestion De Placements Obligations Catastrophe Titres Liés À L'assurance
BRIEF published on 04/07/2025 at 07:06, 1 year 5 months ago BioMérieux obtient le marquage CE pour LUMED™ APSS™ BioMérieux Antibiorésistance Santé Publique Antibiotiques Aide À La Décision
BRIEF published on 04/07/2025 at 07:06, 1 year 5 months ago BioMérieux Achieves CE Marking for LUMED™ APSS™ to Enhance Antimicrobial Stewardship BioMérieux Healthcare Antimicrobial Stewardship CE Marking LUMED APSS
BRIEF published on 04/07/2025 at 07:05, 1 year 5 months ago Julius Baer Introduces Organizational Changes for Enhanced Client Focus Digital Transformation Wealth Management Julius Baer Organizational Change Client Focus
BRIEF published on 04/07/2025 at 07:05, 1 year 5 months ago Julius Baer introduit des changements organisationnels pour une meilleure orientation client Transformation Numérique Julius Baer Gestion De Patrimoine Changement Organisationnel Orientation Client
BRIEF published on 04/07/2025 at 00:10, 1 year 5 months ago Sea Pharmaceuticals Partners with Inotiv to Develop CNS Treatments Sea Pharmaceuticals Inotiv Inc. SPM-0404 CNS Disorders Glutamate Pathway
BRIEF published on 04/07/2025 at 00:10, 1 year 5 months ago Sea Pharmaceuticals s'associe à Inotiv pour développer des traitements du système nerveux central Sea Pharmaceuticals Inotiv Inc. SPM-0404 Troubles Du Système Nerveux Central Voie Du Glutamate
BRIEF published on 04/06/2025 at 18:25, 1 year 5 months ago QIAGEN Reports Strong Q1 2025 Results and Revises EPS Outlook Net Sales Growth EPS Outlook QIAGEN Q1 2025 QuantiFERON Sales QIAstat-Dx Performance
BRIEF published on 04/06/2025 at 18:25, 1 year 5 months ago QIAGEN publie de solides résultats pour le premier trimestre 2025 et révise ses perspectives de bénéfice par action Croissance Des Ventes Nettes QIAGEN T1 2025 Perspectives De BPA Ventes De QuantiFERON Performances De QIAstat-Dx
Published on 09/12/2026 at 02:35, 1 day 2 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 6 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 7 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 12 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 11 hours 21 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 21 hours 41 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 6 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 7 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 9 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 22 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 22 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 9 hours ago Availability of the 2026 Interim Financial Report
